Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry (SchlaHF)
Prevalence, Clinical Characteristics and Type of Sleep-disordered Breathing in Patients With Chronic, Symptomatic, Systolic Heart Failure
Sponsor: ResMed
This observational or N/A phase trial investigates Congestive Heart Failure and Left Ventricular Systolic Dysfunction and is currently completed. ResMed leads this study, which shows 10 recorded versions since 2007 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed
-
Aug 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Aug 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Nov 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ResMed
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aachen, Germany , Adelaide, Australia , Alzey, Germany , Arnsberg, Germany , Auchenflower, Australia , Bad Berka, Germany , Bad Krozingen, Germany , Bad Mergentheim, Germany , Bad Oeynhausen, Germany , Bad Wurzach, Germany and 101 more locations